Fibrin-Targeted Direct Factor Xa Inhibition: Construction and Characterization of a Recombinant Factor Xa Inhibitor Composed of an Anti-Fibrin Single-Chain Antibody and Tick Anticoagulant Peptide

Thrombosis and Haemostasis - Germany
doi 10.1160/th04-01-0047
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Schattauer GmbH

Related search

Antithrombotic Efficacy of Recombinant Tick Anticoagulant Peptide. A Potent Inhibitor of Coagulation Factor Xa in a Primate Model of Arterial Thrombosis

Circulation
Cardiovascular MedicinePhysiologyCardiology
1991English

Rivaroxaban: An Oral Direct Inhibitor of Factor Xa

American Journal of Health-System Pharmacy
MedicineHealth PolicyPharmacologyPharmacy
2008English

Engineered Factor Xa Variants Retain Procoagulant Activity Independent of Direct Factor Xa Inhibitors

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2017English

Antithrombotic Drug and Its Clinical Indication. Factor Xa Inhibitor. Oral Xa Inhibitor (DX-9065a).

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
1996English

Safety, Pharmacokinetics and Pharmacodynamics of Single Doses of Rivaroxaban – An Oral, Direct Factor Xa Inhibitor – In Elderly Chinese Subjects

Thrombosis and Haemostasis
Hematology
2010English

Ixolaris: A Factor Xa Heparin-Binding Exosite Inhibitor

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2005English

Effect of Famotidine on the Pharmacokinetics of Apixaban, an Oral Direct Factor Xa Inhibitor

Clinical Pharmacology: Advances and Applications
Pharmacology
2013English

Factor Xa Inhibitors

2016English

Phosphatidylserine and Factor VA Regulate Factor Xa Structure

Biophysical Journal
Biophysics
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy